RIVOCERANIB: 69 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
69
Total FAERS Reports
5 (7.2%)
Deaths Reported
32
Hospitalizations
69
As Primary/Secondary Suspect
10
Life-Threatening
2
Disabilities
First Report: 201703 · Latest Report: 20250828
What Are the Most Common RIVOCERANIB Side Effects?
#1 Most Reported
Myelosuppression
28 reports (40.6%)
#2 Most Reported
Thrombocytopenia
13 reports (18.8%)
#3 Most Reported
Nausea
11 reports (15.9%)
All RIVOCERANIB Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Myelosuppression | 28 | 40.6% | 2 | 17 |
| Thrombocytopenia | 13 | 18.8% | 1 | 3 |
| Nausea | 11 | 15.9% | 1 | 3 |
| Off label use | 10 | 14.5% | 1 | 3 |
| Anaemia | 9 | 13.0% | 1 | 1 |
| Hypertension | 9 | 13.0% | 0 | 0 |
| Neutropenia | 9 | 13.0% | 0 | 1 |
| Leukopenia | 8 | 11.6% | 0 | 1 |
| Vomiting | 8 | 11.6% | 1 | 2 |
| Diarrhoea | 7 | 10.1% | 0 | 1 |
| Hypothyroidism | 7 | 10.1% | 0 | 0 |
| Pneumonia | 7 | 10.1% | 3 | 4 |
| Rash | 6 | 8.7% | 0 | 0 |
| Decreased appetite | 5 | 7.3% | 0 | 2 |
| Fatigue | 5 | 7.3% | 0 | 1 |
Who Reports RIVOCERANIB Side Effects? Age & Gender Data
Gender: 61.1% female, 38.9% male. Average age: 56.4 years. Most reports from: CN. View detailed demographics →
Is RIVOCERANIB Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2017 | 1 | 1 | 1 |
| 2018 | 1 | 0 | 1 |
| 2020 | 2 | 0 | 1 |
| 2021 | 5 | 0 | 3 |
| 2022 | 1 | 0 | 0 |
| 2023 | 5 | 0 | 3 |
| 2024 | 10 | 1 | 6 |
| 2025 | 5 | 0 | 5 |
What Is RIVOCERANIB Used For?
| Indication | Reports |
|---|---|
| Gastric cancer | 14 |
| Hepatocellular carcinoma | 8 |
| Hepatic cancer | 7 |
Official FDA Label for RIVOCERANIB
Official prescribing information from the FDA-approved drug label.